tiprankstipranks
Trending News
More News >
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market
Advertisement

OptimizeRx (OPRX) Earnings Dates, Call Summary & Reports

Compare
542 Followers

Earnings Data

Report Date
Nov 11, 2025
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.04
Last Year’s EPS
0.12
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Aug 07, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong revenue growth, improved adjusted EBITDA, and significant debt reduction. However, some caution was noted regarding the uncertainty of managed service revenue continuing at the same rate. Overall, the company appears to be on a strong growth trajectory with a solid financial position.
Company Guidance
In the second quarter of fiscal year 2025, OptimizeRx reported substantial growth, with revenues increasing by 55% year-over-year to $29.2 million, surpassing both consensus estimates and internal expectations. Adjusted EBITDA improved significantly, reaching $5.8 million, which is over $5 million more than in the same period last year. The company also announced an upward revision in its annual revenue guidance, projecting revenues between $104 million and $108 million and adjusted EBITDA ranging from $14.5 million to $17.5 million for the year. Furthermore, OptimizeRx has managed to pay down $4.5 million of principal debt, exceeding its scheduled payments by $4 million, thanks to strong free cash flow. The average revenue from its top five customers now exceeds $11 million, and the net revenue retention rate remains robust at 121%. The company continues to innovate with its omnichannel technology platform, enhancing its competitive edge in the digital pharma marketing sector.
Significant Revenue Growth
Q2 2025 revenues increased 55% year-over-year to $29.2 million, surpassing both consensus estimates and internal expectations.
Improved Adjusted EBITDA
Adjusted EBITDA for Q2 2025 was $5.8 million, marking an improvement of over $5 million compared to the previous year.
Debt Reduction
The company paid down $4.5 million of principal during Q2, which was $4 million above the scheduled debt payment.
Increase in Contracted Revenue
Contracted revenue increased by more than 30% year-over-year, positioning the company favorably for the second half of 2025.
High Net Revenue Retention
Net revenue retention rate remained strong at 121%, indicating robust customer retention and expansion.
Strong Financial Position
Operating cash flow was $8.4 million for the first half of 2025, with a cash balance of $16.6 million at the end of the quarter.

OptimizeRx (OPRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OPRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 11, 2025
2025 (Q3)
0.04 / -
0.12
Aug 07, 2025
2025 (Q2)
0.02 / 0.24
0.021100.00% (+0.22)
May 12, 2025
2025 (Q1)
-0.12 / 0.08
-0.11172.73% (+0.19)
Mar 12, 2025
2024 (Q4)
0.27 / 0.30
0.2615.38% (+0.04)
Nov 13, 2024
2024 (Q3)
0.06 / 0.12
0.0933.33% (+0.03)
Aug 08, 2024
2024 (Q2)
-0.06 / 0.02
-0.01300.00% (+0.03)
May 14, 2024
2024 (Q1)
- / -
-0.09
Apr 16, 2024
2023 (Q4)
-0.13 / -0.11
-0.09-22.22% (-0.02)
Nov 06, 2023
2023 (Q3)
0.03 / 0.09
0.0728.57% (+0.02)
Aug 14, 2023
2023 (Q2)
-0.02 / -0.01
0.04-125.00% (-0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

OPRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Aug 07, 2025
$12.84$17.30+34.74%
May 12, 2025
$9.20$11.01+19.67%
Mar 12, 2025
$4.14$6.28+51.69%
Nov 13, 2024
$6.15$4.06-33.98%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does OptimizeRx Corporation (OPRX) report earnings?
OptimizeRx Corporation (OPRX) is schdueled to report earning on Nov 11, 2025, TBA (Confirmed).
    What is OptimizeRx Corporation (OPRX) earnings time?
    OptimizeRx Corporation (OPRX) earnings time is at Nov 11, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OPRX EPS forecast?
          OPRX EPS forecast for the fiscal quarter 2025 (Q3) is 0.04.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis